1. Home
  2. UTHR vs NWSA Comparison

UTHR vs NWSA Comparison

Compare UTHR & NWSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$564.81

Market Cap

23.9B

Sector

Health Care

ML Signal

HOLD

Logo News Corporation

NWSA

News Corporation

HOLD

Current Price

$24.40

Market Cap

14.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTHR
NWSA
Founded
1996
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Newspapers/Magazines
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
23.9B
14.6B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
UTHR
NWSA
Price
$564.81
$24.40
Analyst Decision
Buy
Strong Buy
Analyst Count
14
5
Target Price
$561.57
$37.94
AVG Volume (30 Days)
602.2K
4.6M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
0.82%
EPS Growth
13.07
N/A
EPS
27.86
N/A
Revenue
$1,483,300,000.00
N/A
Revenue This Year
$7.05
$6.06
Revenue Next Year
$13.30
$3.25
P/E Ratio
$20.25
$11.53
Revenue Growth
2.38
N/A
52 Week Low
$266.98
$22.20
52 Week High
$607.89
$31.61

Technical Indicators

Market Signals
Indicator
UTHR
NWSA
Relative Strength Index (RSI) 59.84 51.37
Support Level $464.92 $23.51
Resistance Level N/A $24.60
Average True Range (ATR) 17.36 0.58
MACD 3.23 0.08
Stochastic Oscillator 52.29 44.50

Price Performance

Historical Comparison
UTHR
NWSA

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

About NWSA News Corporation

News Corporation is a diversified media conglomerate with large presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings platform in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.

Share on Social Networks: